Admission troponin T, advanced age and male gender identify patients with improved myocardial tissue perfusion after abciximab administration for ST-segment elevation myocardial infarction.

@article{Lehrke2004AdmissionTT,
  title={Admission troponin T, advanced age and male gender identify patients with improved myocardial tissue perfusion after abciximab administration for ST-segment elevation myocardial infarction.},
  author={Stephanie Lehrke and Evangelos Giannitsis and Hugo A. Katus},
  journal={Thrombosis and haemostasis},
  year={2004},
  volume={92 6},
  pages={
          1214-20
        }
}
The aim was to investigate the effect of abciximab on microvascular perfusion in different subgroups of patients undergoing direct PCI for acute STEMI. We enrolled 145 consecutive patients with TIMI grade 3 flow after direct PCI for acute STEMI. The GPIIb/IIIa inhibitor abciximab was administered in 57 patients (39.3%). Myocardial perfusion was the primary outcome measure and was assessed by analysis of cardiac troponin T wash-out. Treatment effects on myocardial perfusion and clinical outcome… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 42 REFERENCES

TIMI 14 Investigators. Abciximab improves both epicardial flow and myocardial reperfusion in ST-Elevation myocardial infarction. Observations from the TIMI 14 Trial

  • JA De Lemos, EM Antman, M Gibson
  • Circulation
  • 2000
Highly Influential
4 Excerpts

Similar Papers

Loading similar papers…